Frontiers in brain tumor research and empowering women in STEM
Discover the strides being made to unravel the complexities of brain tumors in our latest interview with Karen Noble.
Discover the strides being made to unravel the complexities of brain tumors in our latest interview with Karen Noble.
In this EMA/EORTC workshop, CMF reported its observations and preliminary solutions to address treatment optimisation
Patients with siNETs metastatic to both the liver and peritoneum have favorable outcomes after aggressive surgical cytoreduction, with the best outcomes observed after complete cytoreduction.…
Pembrolizumab monotherapy showed antitumour activity and manageable toxicity in patients with BCG-unresponsive high-risk Ta or T1 bladder cancer without carcinoma in situ and could potentially…
Onyeanunam Ekeke, MBBS, University of Port Harcourt Teaching Hospital, Port Harcourt, Nigeria, discusses the rising rates of prostate cancer in African men. In sub-Saharan Africa,…
Amandeep Salhotra, MD, discusses the feasibility and safety of Orca-T graft in patients undergoing allogeneic transplant for hematologic malignancies.
For patients with polycythemia vera, rusfertide treatment reduces the use of phlebotomy and maintains hematocrit of less than 45 percent.
This clinical care review summarizes government policies for the safe conduct of clinical trials using the telehealth and decentralized clinical trials digital health models.
An abstract is unavailable.
Setanaxib plus pembrolizumab improved progression-free survival and overall survival in recurrent or metastatic head and neck squamous cell carcinoma.
On April 30, 2024, during his first visit to Chile, Rafael Mariano Grossi, Director General of International Atomic Energy Agency (IAEA; Vienna, Austria) and Chile’s…